(Q41377990)

30 September 2017

1 reference

title

Trends in immunotherapy of fungal infections (English)

1 reference

30 September 2017

1 reference

Kullberg BJ

1

1 reference

30 September 2017

publication date

1 January 1997

1 reference

European Journal of Clinical Microbiology & Infectious Diseases

30 September 2017

published in

1 reference

30 September 2017

volume

16

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

51-55

1 reference

https://scigraph.springernature.com/pub.10.1007/bf01575121

30 September 2017

exact match

0 references

cites work

Use of immune modulators in nonspecific therapy of bacterial infections

1 reference

https://api.crossref.org/works/10.1007%2FBF01575121

Cytokine treatment of central nervous system infection: efficacy of interleukin-12 alone and synergy with conventional antifungal therapy in experimental cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01575121

Macrophage colony-stimulating factor induction of enhanced macrophage anticryptococcal activity: synergy with fluconazole for killing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01575121

Antifungal activity of recombinant human macrophage colony-stimulating factor in models of acute and chronic candidiasis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01575121

Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01575121

Protective Effect of Recombinant Human Granulocyte Colony-Stimulating Factor (rG-CSF) against Various Microbial Infections in Neutropenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01575121

Beneficial Effect of Recombinant Human Granulocyte Colony-Stimulating Factor on Fungicidal Activity of Polymorphonuclear Leukocytes from Patients with AIDS

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FBF01575121

21 January 2018

12 December 2020

Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis

1 reference

12 December 2020

Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia.

1 reference

12 December 2020

Enhanced killing of Candida albicans by murine macrophages treated with macrophage colony-stimulating factor: evidence for augmented expression of mannose receptors

1 reference

12 December 2020

Enhancement of oxidative response and damage caused by human neutrophils to Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon

1 reference

12 December 2020

Cytokines in the treatment of fungal infections

1 reference

12 December 2020

The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome

1 reference

12 December 2020

In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease neutrophils to damage Aspergillus hyphae

1 reference

12 December 2020

Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor.

1 reference

12 December 2020

Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and gamma interferon

1 reference

12 December 2020

Neutralization of IL-10 up-regulates nitric oxide production and protects susceptible mice from challenge with Candida albicans

1 reference

12 December 2020

Cure of murine candidiasis by recombinant soluble interleukin-4 receptor

1 reference

12 December 2020

Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice

1 reference

12 December 2020

Tumor necrosis factor and interleukin-6 in Candida albicans infection in normal and granulocytopenic mice

1 reference

12 December 2020

Interleukin-1 alpha administered after autologous transplantation: a phase I/II clinical trial.

1 reference

12 December 2020

Granulocyte colony-stimulating factor potentiates anti-Candida albicans growth inhibitory activity of polymorphonuclear cells

1 reference

12 December 2020

In vivo activity of interferon-gamma in combination with amphotericin B in the treatment of experimental cryptococcosis

1 reference

12 December 2020

Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice

1 reference

12 December 2020

A Controlled Trial of Interferon Gamma to Prevent Infection in Chronic Granulomatous Disease

1 reference

12 December 2020

Immunomodulators and fungal infections: use of antifungal drugs in combination with G-CSF

1 reference

12 December 2020

Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis

1 reference

12 December 2020

Role of granulocytes in increased host resistance to Candida albicans induced by recombinant interleukin-1

1 reference

12 December 2020

Differential gene expression for IL-1 receptor antagonist, IL-1, and TNF receptors and IL-1 and TNF synthesis may explain IL-1-induced resistance to infection.

1 reference

12 December 2020

Protection of neutropenic mice from lethal Candida albicans infection by recombinant interleukin 1.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01575121

1 reference

Dimensions Publication ID

30 September 2017

1033441615

0 references

1 reference